For this purpose, we searched Google Scholar, PubMed, EBSCOhost and WEB of Science electronic databases for publications up to September 2025
High-protein foods first at every meal, protein-forward snacks when you can tolerate them, and potentially protein shakes in formats that are easy on a nauseous stomach
These minor changes are often made solely to create the illusion that the patient requires a unique compounded formulation when, in reality, they do not. Whats particularly telling is that many compounding pharmacies are offering the same additives or minor adjustments to large numbers of patientsi.e., mass personalizationwhich clearly demonstrates a violation of FDA requirements for individualized compounding. FDA, Eli Lilly and Novo Nordisk Agree on Compounded GLP-1 Medications The FDA makes it clear: providers should not sell or market compounded GLP-1 medications like semaglutide and tirzepatide unless a patient has a legitimate, documented clinical need
The Phase 3 TRIUMPH-1 results released in May 2026 told a similar story: the common side effects were nausea, diarrhoea, constipation, vomiting, an altered skin sensation called dysesthesia, and urinary and respiratory infections
Thats normaland its a signal to adjust your approach, not abandon it
In my experience, tirzepatide patients hit plateau less frequently and later in their treatment course than semaglutide patients